Adverse Effects of Highly Active Antiretroviral Therapy in Developing Countries
Open Access
- 15 October 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (8) , 1093-1101
- https://doi.org/10.1086/521150
Abstract
Recent increases in access to highly active antiretroviral therapy (HAART) have made the management of drug toxicities an increasingly crucial componKeywords
This publication has 93 references indexed in Scilit:
- Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, MalawiTropical Medicine & International Health, 2005
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001AIDS, 2003
- Population pharmacokinetic meta-analysis with efavirenzInt. Journal of Clinical Pharmacology and Therapeutics, 2002
- Population pharmacokinetics of nevirapine in an unselected cohort of HIV‐1‐infected individualsBritish Journal of Clinical Pharmacology, 2002
- Immune Reconstitution Inflammatory SyndromeMedicine, 2002
- Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infectionsHepatology, 2002
- Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected PatientsThe Journal of Infectious Diseases, 2000
- Peripheral Neuropathy with Nucleoside AntiretroviralsDrug Safety, 1998
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987